Molecular and Microbiota Signatures Underlying Colonic Diverticular Disease
NCT ID: NCT06764550
Last Updated: 2025-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
150 participants
OBSERVATIONAL
2020-03-05
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Probiotic on Diverticular Symptoms
NCT02115867
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550
Probiotic After Acute Colonic Diverticulitis
NCT06040515
Evaluation of the Metabolome in Diverticular Disease
NCT01831323
Changes of Microbiota in Irritable Bowel Syndrome Patients
NCT01679730
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy subjects
Subjects who are asymptomatic for digestive symptoms and without diverticula.
This is an observational study, participants are not assigned an intervention as part of the study.
This is an observational study, participants are not assigned an intervention as part of the study.
Patients with diverticulosis
Patients with diverticula and without symptoms.
This is an observational study, participants are not assigned an intervention as part of the study.
This is an observational study, participants are not assigned an intervention as part of the study.
Patients with symptomatic uncomplicated diverticular disease
Patients with diverticula and with symptoms.
This is an observational study, participants are not assigned an intervention as part of the study.
This is an observational study, participants are not assigned an intervention as part of the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
This is an observational study, participants are not assigned an intervention as part of the study.
This is an observational study, participants are not assigned an intervention as part of the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Belonging to one of the following groups:
1. Patients with diverticula of the colon without symptoms.
2. Patients symptomatic for diverticular disease.
3. Subjects undergoing colonoscopy for colorectal cancer prevention or follow-up of previous polypectomies, asymptomatic for digestive symptoms.
* Obtaining informed consent.
Exclusion Criteria
* Previous colon surgery
* Antibiotics or laxatives within the past 90 days
* Pregnancy and/or lactation
* Systemic and psychiatric disorders
* Asthma, food allergies and other allergic-type disorders
* Possible diseases leading to intestinal bacterial contamination (diabetes, blind loop syndrome, rheumatologic diseases).
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Raffaella Barbaro, Biologist
Role: PRINCIPAL_INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GR-2018-12367062
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
GR-Barbaro
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.